What Is 5-Amino-1MQ? Mechanism and Preclinical Research Summary

At a glance: Understanding 5-Amino-1MQ in research

5-Amino-1MQ is a membrane-permeable quinolinium derivative that specifically blocks the enzyme nicotinamide N-methyltransferase (NNMT). By inhibiting NNMT activity in tissue models, the compound prevents the irreversible methylation of nicotinamide, preserving critical precursors within the NAD+ salvage pathway.

Preclinical studies indicate that NNMT suppression by 5-Amino-1MQ leads to increased intracellular NAD+ concentrations, enhanced mitochondrial respiration, elevated basal metabolic rate, and reduced lipid accumulation in adipocytes.

Unlike biological peptides, 5-Amino-1MQ is a synthetic small-molecule research compound requiring precise chemical characterization, purity verification, and mass spectrometry validation before deployment in quantitative assays.

What is 5-Amino-1MQ? Chemical profile and development background

When investigating what 5-Amino-1MQ is, researchers encounter a distinct small molecule categorized structurally as a methylated quinolinium salt. Its chemical designation is 5-amino-1-methylquinolin-1-ium, carrying a molecular weight of approximately 159.21 g/mol in its core cation form. Developed through structural activity relationship (SAR) studies targeting metabolic enzymes, 5-Amino-1MQ was engineered to overcome the poor selectivity and limited membrane permeability of early-generation NNMT inhibitors.

Nicotinamide N-methyltransferase is a cytosolic enzyme expressed heavily in white adipose tissue, the liver, and select parenchymal organs. NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), generating 1-methylnicotinamide (MNA) and S-adenosylhomocysteine (SAH). Because MNA is excreted in urine, NNMT activity effectively drains the pool of free nicotinamide available for NAD+ synthesis.

By binding directly to the active catalytic site of NNMT, 5-Amino-1MQ arrests this depletion pathway. Researchers interested in investigating these metabolic mechanisms can order 5-Amino-1MQ 5mg vials directly from PX1 Research, or review our comprehensive product documentation on our dedicated 5-Amino-1MQ research compound page.

What is the molecular mechanism of action for 5-Amino-1MQ?

The molecular mechanism of 5-Amino-1MQ centers on competitive enzyme inhibition within the nicotinamide salvage pathway. In normal cellular physiology, nicotinamide phosphoribosyltransferase (NAMPT) converts nicotinamide into nicotinamide mononucleotide (NMN), which is subsequently converted into oxidized nicotinamide adenine dinucleotide (NAD+). High levels of NNMT enzyme expression compete with NAMPT for available nicotinamide substrate.

In vitro kinetic studies demonstrate that 5-Amino-1MQ acts as a potent, selective inhibitor of NNMT with nanomolar-to-low-micromolar inhibitory constants (IC50 ~ 1.2 µM). By blocking NNMT activity, 5-Amino-1MQ produces three distinct biochemical outcomes within cellular models:

1. Preservation of Nicotinamide: Prevents the conversion of NAM into 1-MNA, ensuring substrate availability for NAMPT-mediated NAD+ biosynthesis.

2. Normalization of Methyl Group Donors: Reduces the excessive consumption of S-adenosylmethionine (SAM), helping maintain favorable SAM/SAH ratios necessary for epigenetic DNA and histone methylation.

3. Stimulation of Sirtuin Activity: Secondary elevation of intracellular NAD+ pools activates NAD+-dependent deacetylases (SIRT1, SIRT3), driving mitochondrial biogenesis and metabolic gene expression.

Laboratories evaluating metabolic signaling pathways across our full catalog of research peptides utilize 5-Amino-1MQ as a benchmark tool for dissecting NNMT-dependent regulation of cellular energetics.

How does 5-Amino-1MQ influence NAD+ dynamics and mitochondrial output?

Intracellular NAD+ concentrations dictate the efficiency of electron transport chain complexes, oxidative phosphorylation, and cellular ATP yield. In aging or high-fat challenge models, NNMT expression is upregulated in adipose tissues, resulting in reduced NAD+ availability and suppressed mitochondrial respiration.

Preclinical studies show that treating cultured adipocytes and skeletal muscle cells with 5-Amino-1MQ restores intracellular NAD+ levels toward baseline. This NAD+ expansion correlates directly with increased oxygen consumption rate (OCR), elevated ATP production, and enhanced transcription of mitochondrial genes, including peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α).

Compared to direct NAD+ precursors or mitochondrial-targeted signaling agents like MOTS-c research reagent, 5-Amino-1MQ operates upstream by halting the enzymatic consumption of endogenous nicotinamide. This unique entry point allows researchers to isolate the specific contribution of NNMT suppression from general NAD+ supplementation.

Preclinical research models: Lipid metabolism and adipocyte dynamics

The primary body of literature surrounding 5-Amino-1MQ focuses on rodent models of diet-induced obesity and metabolic dysregulation. In high-fat diet rodent assays, administration of 5-Amino-1MQ led to significant reductions in adipocyte volume and total body fat mass without alterations in caloric intake.

Key preclinical findings in adipose tissue models include:

- Decreased Intracellular Lipid Accumulation: In vitro differentiation assays show reduced triglyceride accumulation during adipogenesis when NNMT is inhibited.

- Upregulation of Energy Expenditure: Indirect calorimetry in animal models reveals elevated resting metabolic rates and increased heat dissipation.

- Improved Glucose Homeostasis: Rodent studies document enhanced insulin sensitivity and reduced fasting blood glucose levels following sustained NNMT inhibition.

To complement lipid regulation assays, many research protocols pair 5-Amino-1MQ alongside lipolytic peptides such as AOD-9604 vials to study multi-target metabolic pathways. Researchers can explore additional molecular targets in our dedicated scientific research library.

Comparing 5-Amino-1MQ with other metabolic research compounds

To design effective comparative trials, research teams must understand how 5-Amino-1MQ differs from other metabolic and weight-regulation research reagents:

- Target Class: 5-Amino-1MQ is an intracellular enzyme inhibitor (NNMT), whereas compounds like Retatrutide 10mg vials act as cell-surface peptide receptor agonists (GIP/GLP-1/Glucagon receptors).

- Primary Pathway: 5-Amino-1MQ alters intracellular metabolite concentrations (NAD+, SAM, SAH), while peptide secretagogues alter hormonal cascades and appetite-regulating signaling.

- Molecule Type: 5-Amino-1MQ is a rigid, synthetic small molecule with high oral and cell-membrane bioavailability, whereas peptides consist of amino acid chains prone to rapid enzymatic cleavage.

- Application Focus: 5-Amino-1MQ is selected specifically for cellular energy, mitochondrial biogenesis, and localized adipocyte flux assays.

Benchmark criteria for sourcing high-purity 5-Amino-1MQ

Because 5-Amino-1MQ is a small molecule synthetic salt, rigorous analytical chemistry protocols must be applied during production and quality control to ensure reproducible experimental results.

Standard laboratory specifications for 5-Amino-1MQ include:

- Purity Verification: High-Performance Liquid Chromatography (HPLC) confirming chromatogram purity equal to or exceeding 98.0%.

- Mass Identification: Liquid Chromatography-Mass Spectrometry (LC-MS) verifying exact molecular mass (m/z) and confirming the absence of unreacted synthetic intermediates.

- Endotoxin & Residue Limits: Kinetic Chromogenic LAL testing ensuring endotoxin levels remain below strict threshold values (< 0.01 EU/mg) for cell culture compatibility.

- Sourcing Transparency: Full synthesis traceable to USA-based laboratories under standardized chemical manufacturing controls.

- Immediate Transit: Controlled temperature packaging shipped rapidly from domestic hubs to maintain solid-state stability.

How to vet a supplier: Red flags in the research compound market

Selecting an unreliable vendor introduces compounding variables that ruin trial repeatability. Laboratories should audit chemical vendors against known red flags before procurement:

1. Missing Raw LC-MS / HPLC Spectra: Vendors offering simple PDF certificates without raw chromatographic data, retention times, and spectral peak integrations fail basic verification standards.

2. Absence of Endotoxin Quantitation: Small molecules used in cell culture assays can carry bacterial endotoxins or solvent residues if purification steps are bypassed.

3. Lack of Batch Traceability: Generic lot numbers that do not match individual batch synthesis records indicate pooled or unverified third-party distribution.

4. Non-Compliant Human Claims: Vendors promoting small molecules with dosing advice, body-recomposition claims, or human consumption instructions violate regulatory compliance and signal unvetted retail operations.

PX1 Research maintains complete transparency by publishing full raw analytical data for every production batch on our site. Bulk buyers can review expanded procurement protocols on our wholesale peptide supply portal.

Laboratory protocols: Reconstitution, solubility, and storage

5-Amino-1MQ is delivered as a lyophilized or crystalline solid powder. Strict handling protocol maintains chemical stability over extended research timelines:

- Dry Storage: Store solid powder at -20°C in a desiccated environment away from direct light. Lyophilized powder remains stable for up to 24 months under these conditions.

- Reconstitution / Solvents: 5-Amino-1MQ exhibits high solubility in Dimethyl Sulfoxide (DMSO) up to 20 mg/mL and moderate solubility in sterile deionized water or phosphate-buffered saline (PBS).

- Working Solutions: Once dissolved in aqueous buffer or DMSO, aliquot into single-use experimental volumes to avoid repeated freeze-thaw cycles. Store liquid aliquots at -80°C for long-term stability.

Prior to initiating in vitro assays, verify complete dissolution by visual inspection and gentle vortexing.

Ordering 5-Amino-1MQ from PX1 Research

When your laboratory requires uncompromised chemical purity and fully documented lot traceability, PX1 Research delivers. Every batch of 5-Amino-1MQ undergoes dual-tier verification, combining quantitative HPLC mass distribution with bacterial endotoxin testing.

What your lab receives with every order:

- Sealed, high-purity glass vials containing verified 5-Amino-1MQ solid powder.

- Direct access to lot-specific Certificate of Analysis (COA) containing raw HPLC and LC-MS spectra via QR code or online portal.

- Same-day dispatch from our California and Arizona fulfillment centers for orders placed before 3 PM EST / 12 PM PST Monday through Friday.

- Tracked domestic shipping with temperature-monitored transit options.

- Rapid technical support from experienced team members dedicated to research compliance.

Ready to advance your metabolic research protocols? Buy 5-Amino-1MQ 5mg vials directly from PX1 Research today or explore our full catalog of research compounds.